II Clinic of Cardiology, Nicolaus Copernicus University in Toruń, L. Rydygier Collegium Medicum in Bydgoszcz, University Hospital No 2 in Bydgoszcz, Poland.
Arch Med Sci. 2011 Jun;7(3):449-56. doi: 10.5114/aoms.2011.23411. Epub 2011 Jul 11.
The growing number of heart failure (HF) patients is becoming an important issue in cardiology. B-type natriuretic peptide (BNP) is a recognized marker of HF, including in patients with preserved systolic function. The TEI index is an indicator of left ventricular function. The aim of the study was to evaluate the relationship between BNP serum level, TEI index and the degree of diastolic dysfunction in patients with HF symptoms and preserved systolic function.
Hundred patients with arterial hypertension and preserved systolic function were enrolled in the study. The study group consisted of 51 individuals with impaired diastolic function and HF symptoms. Fourty-nine hypertensive individuals without HF symptoms were assigned to the control group. B-type natriuretic peptide and echocardiographic examination were performed. Patients were divided into 4 subgroups - with normal diastolic function, impaired relaxation, pseudonormalization and restriction.
Median value of BNP in patients with normal diastolic function was 28.36 pg/ml, 87.10 pg/ml in patients with impaired relaxation, 212.75 pg/ml and 461.56 pg/ml in the pseudonormalization and restriction group respectively (p < 0.0001). The median value of the TEI index was: 0.386 in patients with normal diastolic function, 0.507 in individuals with impaired relaxation, 0.639 and 0.725 in the pseudonormalization and restriction group respectively. All the differences were statistically significant (p < 0.0001). A significant positive correlation (r = 0.80, p < 0.001) between BNP and the TEI index was found.
In hypertensive patients with HF symptoms and preserved left ventricular systolic function a highly significant increase in BNP serum level and in the TEI index values related to the deterioration of diastolic dysfunction was found.
心力衰竭(HF)患者数量的增加正在成为心脏病学中的一个重要问题。B 型利钠肽(BNP)是心力衰竭的公认标志物,包括在左心室收缩功能保留的患者中。TEI 指数是左心室功能的指标。本研究旨在评估心力衰竭症状和左心室收缩功能保留的患者中 BNP 血清水平、TEI 指数与舒张功能障碍程度之间的关系。
纳入了 100 名患有动脉高血压和左心室收缩功能保留的患者进行研究。研究组由 51 名舒张功能障碍和心力衰竭症状的患者组成。49 名无心力衰竭症状的高血压患者被分配到对照组。进行了 B 型利钠肽和超声心动图检查。患者被分为 4 个亚组 - 正常舒张功能、松弛不良、假性正常化和限制。
正常舒张功能患者的 BNP 中位数为 28.36pg/ml,松弛不良患者为 87.10pg/ml,假性正常化和限制组分别为 212.75pg/ml 和 461.56pg/ml(p<0.0001)。TEI 指数的中位数分别为:正常舒张功能患者为 0.386,松弛不良患者为 0.507,假性正常化和限制组分别为 0.639 和 0.725。所有差异均具有统计学意义(p<0.0001)。发现 BNP 和 TEI 指数之间存在显著正相关(r=0.80,p<0.001)。
在有心力衰竭症状和左心室收缩功能保留的高血压患者中,发现 BNP 血清水平和与舒张功能障碍恶化相关的 TEI 指数值显著增加。